#Mcneill dysphagia 2020 course professional#

Tobacco and alcohol have long been considered as the main causes of HNC. It is estimated that approximately 151,000 new patients will be affected by HNC in Europe in 2020. The majority of these cancers are located in the oral cavity including the lip and, in the larynx, followed by the pharynx. Globally, HNC affected approximately 686,328 individuals in 2012. The incidence rates of each cancer type vary according to geographic region, age, gender, and various risk factors. More than 90% of these cancers are squamous cell carcinomas. HNC comprises epithelial tumors of the nasal cavity and paranasal sinuses, nasopharynx, hypopharynx, larynx, oropharynx, oral cavity, lip, and malignant tumors of the salivary glands. HNC is one of the most common malignancies in the world, with high mortality rates. Wherever possible, a section was supported by a systematic literature review and we aimed to provide an up-to-date overview of what we believe should be essential core knowledge for health professionals and what should be the minimum standard of care for OD in the HNC setting.Д®tiology, epidemiology, and survival of head and neck cancer

#Mcneill dysphagia 2020 course professional#

A concept document comprising HNC-related topics acted as a foundation for the mandated contributors to add topics or ideas from their professional perspective. It comprises 24 sections covering all aspects of head and neck oncology in a broad sense including legal and ethical issues. The document was written by experts from the ESSD, the Confederation of European Otorhinolaryngology Head and Neck Surgery (CEORL-HNS), the European Head and Neck Society (EHNS), the Union of the European Phoniatricians (UEP), and the European Laryngological Society (ELS). The purpose of this document is to inform key stakeholders including health professionals from the various disciplines involved in the management of OD associated with HNC about the state of the art with regard to the different aspects of care. Given the need for a consensus across Europe for the treatment of OD in head and neck cancer (HNC), The European Society for Swallowing Disorders (ESSD) initiated an alliance with relevant European professional medical and multidisciplinary societies to write a White Paper on this topic. The state of the art and minimum standards of oropharyngeal dysphagia (OD) care will vary by country across Europe and will depend on the setting of the medical care, the cultural and religious background of the population, and the vision and resources available to policymakers. Meanwhile, its management remains a challenge for European professional associations and policymakers. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future.

The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. Twenty-four sections on HNC-specific OD topics. Evidence is based on systematic reviews, consensus-based position statements, and expert opinion. MethodsД®xperts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. There are wide variations in the management of OD associated with HNC across Europe. To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). European white paper: oropharyngeal dysphagia in head and neck cancer